BVMF/A2LC34 (BVMF/A2LC34)

Brazil Stock Exchange: BVMF/A2LC34 · BRL

R$37.7

+0.00 (0.0%)· Recorded snapshot

Market cap	179.6B
Revenue (ttm)	56.3B
Net income (ttm)	3.3B
EPS (ttm)	R$0.68
P/E (trailing)	55.2x
P/E (forward)	17.5x
Dividend	R$0.11 (0.30%)
Volume	35

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 56.3B
Net income (ttm): 3.3B
EPS (ttm): R$0.68
P/E (trailing): 55.2x
P/E (forward): 17.5x
Market cap: 179.6B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E17.5

P25 n/aP50 n/aP75 n/a

Trailing P/E55.2

P25 n/aP50 n/aP75 n/a

ROE2.9

P25 n/aP50 n/aP75 n/a

ROIC4.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/A2LC34 indicators

Market & fundamental data

Available fields

230

Groups with data

Currency

USD

Showing 230 of 230 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	Switzerland
Country code	BR
Earnings date	2026-11-11
Employees	25,000
Employees change	0
Employees growth	0%
Enterprise value	BRL 199.6B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1945
Industry	Medical Instruments & Supplies
Is primary listing	No
ISIN number	BRA2LCBDR004
Last earnings date	2026-08-11
Last refreshed	2026-10-28
Market cap	BRL 179.6B
Next earnings date	2026-11-11
Price	BRL 37.74
Price currency	BRL
Sector	Healthcare
SIC code	3851
Stock price date	2026-10-26
Symbol	bvmf/A2LC34
Website	https://www.alcon.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (3Y)	44.99x
Average P/E ratio (5Y)	65.11x
Earnings yield	1.81%
EV/Earnings	59.93x
EV/EBIT	27.55x
EV/EBITDA	15.38x
EV/FCF	22.14x
EV/Sales	3.53x
FCF / EV yield	4.52%
FCF yield	5.02%
Forward P/E	17.55x
Graham number	19.24404
Graham upside	-49.01%
Lynch fair value	BRL 17.50
Lynch upside	-53.63%
P/(FCF - SBC) ratio	22.11x
P/(OCF - SBC) ratio	16.21x
P/B ratio	1.61x
P/E ratio	55.24x
P/FCF ratio	19.92x
P/OCF ratio	15.01x
P/S ratio	3.19x
Price / tangible book value	8.53x
Price/EBITDA ratio	14.42x
Sector forward P/E	11.27x
Sector P/E	41.78x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	12.88%
EBITDA margin	22.13%
Effective tax rate	13.23%
FCF margin	15.51%
Gross margin	57.22%
Operating margin	12.88%
Pretax margin	6.82%
Profit margin	5.92%
Profit per employee	BRL 133,250
Profitable years	5
Revenue per employee	BRL 2.3M
ROA	2.8%
ROA (5Y)	2.31%
ROCE	5.01%
ROE	2.94%
ROE (5Y)	3.57%
ROIC	4.75%
ROIC (5Y)	3.89%
SBC / revenue	1.58%
Tax / revenue	0.9%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-39.24%
EPS growth 10Y	-14.86%
EPS growth 3Y	21.53%
EPS growth 5Y	28.69%
EPS growth years	3
FCF growth	7.54%
FCF growth (Q)	2.73%
FCF growth (QoQ)	48.39%
FCF growth 3Y	48.16%
FCF growth 5Y	17.59%
Gross profit growth	11.58%
Gross profit growth (Q)	17.05%
Gross profit growth 3Y	7.38%
Gross profit growth 5Y	8.8%
Net income growth	-40.08%
Net income growth 3Y	21.11%
Net income growth 5Y	28.57%
Net income growth years	3
OCF growth	10.26%
OCF growth (Q)	0.99%
OCF growth (QoQ)	22.01%
OCF growth 10Y	0.9%
OCF growth 3Y	25.92%
OCF growth 5Y	12.06%
Operating income growth	8.53%
Operating income growth (Q)	42.41%
Operating income growth 3Y	14.99%
Operating income growth 5Y	21.8%
Revenue growth	8.34%
Revenue growth (Q)	8.74%
Revenue growth (QoQ)	4.32%
Revenue growth 10Y	5.63%
Revenue growth 3Y	6.13%
Revenue growth 5Y	6.8%
Revenue growth quarters	23
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -3B
Depreciation and amortization	BRL 5.4B
EBIT	BRL 7.2B
EBITDA	BRL 12.5B
EPS	BRL 0.68
Financing cash flow	BRL -6.6B
Free cash flow	BRL 9B
Free cash flow minus SBC	BRL 8.1B
Gross profit	BRL 32.2B
Income taxes	BRL 507.7M
Investing cash flow	BRL -5.5B
Net borrowing	BRL -460.1M
Net cash flow	BRL -274.6M
Net income	BRL 3.3B
Operating cash flow minus SBC	BRL 11.1B
Operating income	BRL 7.2B
Revenue	BRL 56.3B
Stock-based compensation	BRL 891.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	BRL 231.44
Debt / EBITDA	2.12
Debt / equity	0.25
Debt / FCF	3.05
Goodwill	BRL 49.5B
Interest coverage	6.69
Long-term assets	BRL 125.7B
Long-term liabilities	BRL 32.3B
Net cash (debt)	BRL -19.9B
Net cash / market cap	-11.08%
Net debt / EBITDA	1.6
Net debt / equity	0.18
Net debt / FCF	2.21
Piotroski F-Score	7
Property, plant and equipment	BRL 28.1B
Shareholders' equity	BRL 111.9B
Tangible book value	BRL 21.1B
Tangible book value per share	BRL 43.58
Total assets	BRL 161.1B
Total cash	BRL 7.5B
Total debt	BRL 27.5B
Total liabilities	BRL 49.2B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.35
Current assets	BRL 35.4B
Current liabilities	BRL 16.9B
Current ratio	2.09
Inventory turnover	1.89
Net working capital	BRL 13.7B
Quick ratio	1.12
Working capital	BRL 17.9B
Working capital turnover	15.33

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.24%
Dividend growth	-1.63%
Dividend growth (3Y)	10.19%
Dividend growth years	3
Dividend payment date	2026-05-13
Dividend payment years	5
Dividend payout frequency	Annual
Dividend per share	BRL 0.11
Dividend yield	0.3%
Ex-dividend date	2026-05-05
Last dividend	BRL 0.02
Payout ratio	27.06%
Shareholder yield	1.53%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 44.33
1D price change	0%
1M price change	-0.68%
1M total return	-0.68%
1W price change	20.46%
1W total return	20.46%
1Y price change	-8.6%
1Y return CAGR	-8.33%
1Y total return	-8.33%
20-day SMA	BRL 35.22
200-day SMA	BRL 42.29
3M price change	10.74%
3M total return	10.74%
3Y price change	0.03%
3Y return CAGR	0.25%
3Y total return	0.74%
50-day SMA	BRL 38.76
50-day SMA vs 200-day SMA	50under200
52-week high	BRL 45.00
52-week high date	2025-12-22
52-week low	BRL 30.88
52-week low date	2026-05-12
6M price change	-6.12%
6M total return	-5.84%
All-time high	BRL 56.76
All-time high date	2024-09-12
All-time low	BRL 30.35
All-time low date	2022-10-20
Average true range (ATR)	BRL 1.70
Average volume	118.8
Change from 52-week high	-16.13%
Change from 52-week low	22.22%
Change from all-time high	-33.51%
Change from all-time low	24.35%
Change from open	0.16%
Dollar volume	BRL 1,321
High price	BRL 37.74
Low price	BRL 37.68
Monthly RSI	42.83
Open price	BRL 37.68
Position in 52-week range	100%
Price vs 150-day SMA	-14.87%
Price vs 20-day SMA	7.15%
Price vs 200-day SMA	-10.76%
Price vs 50-day SMA	-2.63%
Relative volume	0.29
RSI	52.9
Sharpe ratio	0.06
Sortino ratio	0.2
Volume	35
Weekly RSI	43.88
YTD price change	-16.13%
YTD total return	-15.88%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	481.8M
Shares change (QoQ)	-0.31%
Shares change (YoY)	-1.24%
Shares held by insiders	0.17%
Shares held by institutions	57.89%

Deeper analysis on BVMF/A2LC34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/A2LC34 report

Is a complete BVMF/A2LC34 research report available?

No complete published report is available for bvmf/A2LC34 (BVMF/A2LC34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/A2LC34 (BVMF/A2LC34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/A2LC34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/A2LC34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/A2LC34

Frequently asked questions